“REDUCTION IN CONTROLLED ATTENUATION PARAMETER AND LIVER STIFFNESS WITH SAROGLITAZAR IN NAFLD: A PROSPECTIVE ANALYSIS”. International Research Journal of Pharmacy 16, no. 2 (February 17, 2025): 38–49. Accessed August 3, 2026. https://irjponline.org/index.php/irjp/article/view/3330.